The Role of Cross-Industry Innovation in Executive Leadership
Leaders with diverse industry experience bring fresh perspectives to organisations, fostering innovation and creative problem-solving....
Life Sciences and Healthcare Executive Search
Adastrum is a London executive search and leadership advisory firm. We appoint chief executives, chief operating and commercial officers, and technology and transformation leadership into life sciences, biotech, medtech and healthcare businesses.
This is a sector where change has to be delivered inside a regulatory perimeter, on timelines nobody controls, and where the cost of the wrong appointment is counted in more than money.
Talk to us about a senior appointmentRetained Executive Search for Life Sciences and Healthcare Leadership
We are retained by boards, chief executives, investors and chief people officers to appoint the executive leadership of a life sciences or healthcare business. Retained means we are engaged to solve a defined problem rather than to fill a vacancy: we map the whole relevant market, approach leaders confidentially, assess them against the problem, and stay involved through the offer and the first hundred days.
The businesses that retain us are usually at a hinge point. A discovery pipeline that has to industrialise. A product that has cleared approval and now has to sell. A care provider whose digital estate can no longer support the service model. Before we open a search we agree what the appointment actually has to change, because in this sector a well-qualified leader pointed at the wrong problem costs a great deal more than a delay.
Leadership Challenges Facing Life Sciences and Healthcare Businesses
Briefs in this sector arrive wrapped in science, regulation or clinical language. Underneath, they reduce to a small number of leadership problems.
- The science works and the company does not yet. Approval has been won, and the organisation now needs commercial leadership without losing the rigour that got it there.
- Transformation has to happen inside a regulatory perimeter. The change is necessary, the validation burden is real, and the margin for improvisation is narrower than in any other sector we work in.
- A digital and data estate cannot support the service model. Systems bought one problem at a time are now being asked to carry a single patient or customer experience.
- Quality or compliance has become a leadership problem. After an inspection or an incident, the process is rarely the whole story. The question is who was willing to say so beforehand.
- An investor thesis has a clock on it. A buy-and-build or a value creation plan needs delivery inside a hold period, and the founding team has not run at this scale before.
Life Sciences and Healthcare Leadership Roles We Appoint
We are retained to appoint permanent and interim executive leadership, including
- Chief Executive, Chief Operating Officer and Chief Commercial Officer
- Chief Business Officer
- Chief Technology Officer, Chief Information Officer and Chief Digital Officer
- Chief Data Officer and Head of Data Strategy
- Directors of Transformation, Programme and Change
- Board, non-executive and advisory appointments
Our work is the executive leadership that runs and transforms a life sciences or healthcare business. We do not place clinicians, nurses, scientists, researchers or other practitioner roles, we do not work below director level, and we are not a contingent agency. If that is what you need, we will gladly point you to someone better placed to help.
Healthcare & Life Sciences Executive Search at a Glance
The scope of a mandate, in short. Where a brief falls outside it we will say so at the first conversation rather than three weeks in.
| Scope | What we do |
|---|---|
| Roles in scope | Chief Executive, Chief Operating Officer and Chief Commercial Officer. Chief Business Officer. Chief Technology Officer, Chief Information Officer and Chief Digital Officer. Chief Data Officer and Head of Data Strategy. Directors of Transformation, Programme and Change. Board, non-executive and advisory appointments. |
| Roles out of scope | Clinicians, nurses, scientists, researchers and other practitioner roles, and anything below director level. We are not a contingent agency. |
| Seniority | Director level and above, up to and including the board. |
| Engagement basis | Retained. We are not a contingent agency and do not work on percentage-of-placement terms. |
| Typical timeline | Shortlist four to six weeks from briefing. Eight to twelve weeks from briefing to accepted offer. Interim leaders can be in the seat within days. |
Our Life Sciences Executive Search Process
Five stages, run the same way on every mandate, with the diligence a regulated environment requires built into each one.
Stage 1
Defining the problem
We establish what the appointment has to change, what the regulatory and clinical constraints genuinely permit, and what the organisation will let a new leader do. We will challenge a specification that asks for a scientist, a commercial operator and a transformation leader in one person, because that brief is common and it is how a search quietly runs for nine months.
Stage 2
Research and market mapping
We map the relevant market comprehensively: leaders inside life sciences and healthcare, and those in adjacent regulated industries whose experience transfers. We approach each personally and confidentially. Where deep therapeutic or clinical knowledge genuinely is the constraint rather than a preference, we say so and we narrow the map accordingly.
Stage 3
Approach and assessment
Assessment is a subject-matter conversation between peers, not a scripted competency exercise. In a regulated business we weight one thing heavily: how a candidate behaves when the honest answer is unwelcome. Each shortlisted candidate receives a written assessment covering track record, behaviour under pressure and the risks attached to appointing them.
Stage 4
Shortlist and decision
We present three to five candidates with our recommendation, the trade-offs between them, and what we would do if it were our decision. We are explicit about the trade a board is usually making here, which is between scientific credibility and commercial pace, and about which of the two this particular business can least afford to be short of.
Stage 5
Offer, onboarding and the first hundred days
We manage the offer and stay close to the leader and the sponsor through the first hundred days. In this sector the first real test is usually a decision where the compliant answer and the fast answer differ, and how a new leader handles it sets the tone for everything after.
How We Assess Life Sciences and Healthcare Leaders
A strong CV from a well-known pharmaceutical, biotech or care business is a safe-looking choice in a board pack. It tells you what someone has been part of. It does not tell you how they will lead when a trial reads badly, a regulator asks a question nobody prepared for, or a launch timeline slips through no fault of the team.
Working with the social psychologist Dr Ian Stewart, we assess how a leader operates when the room is calm and what they reach for when it is not. Those defaults are developable rather than fixed, which is the useful part: a leader who can see their own can regulate it. In a regulated environment, where the pressure to give the reassuring answer is constant, that behavioural read matters more rather than less.
Cross-Sector Search for Healthcare and Life Sciences Leadership
We place across sectors on purpose. The pattern recognition that changes an outcome usually travels better from outside an industry than from within it, because people inside a sector have often arrived at the same answers as one another.
A leader who has already taken a business from single product to platform, or already run technology at pace under real regulatory accountability, carries that judgement whatever industry earned it. We map inside and outside the sector and let the problem decide. Where therapeutic depth or clinical credibility is genuinely the constraint, we will tell you, and we will not put forward someone who cannot hold the room on the science.
Why Boards Choose Adastrum for Life Sciences Executive Search
Adastrum brings twenty years of appointing senior leaders into complex organisations, a behavioural assessment method developed with the social psychologist Dr Ian Stewart, and our Meta Team programme, which has worked with leadership teams at organisations including Nasdaq, Novartis, HSBC, Unilever and EQT.
Life Sciences Executive Search: Frequently Asked Questions
No. We appoint the executive leadership that runs and transforms a business: chief executives, chief operating and commercial officers, chief technology and information officers, and transformation directors. We do not place practising clinicians, nurses, laboratory scientists or research staff.
Biotech and pharmaceutical businesses, medtech and diagnostics companies, digital health and health technology firms, private care providers, and investor-backed healthcare groups. The common thread is an organisation at a hinge point where one senior appointment carries a disproportionate share of the plan.
The service is specialist; the firm is not, deliberately. Our specialism is leadership: defining the problem an organisation needs to solve and assessing how a leader will behave under pressure. That method travels across industries, and in a regulated sector it is often what distinguishes a durable appointment from a well-credentialled one.
Sometimes, and we will tell you honestly when the answer is yes. For scientific and medical leadership it usually is. For commercial, operational and technology leadership it frequently is not, and insisting on it narrows the field to the same small pool your competitors are hiring from.
Most mandates reach shortlist four to six weeks after briefing and run eight to twelve weeks to accepted offer. Appointments requiring specific therapeutic depth, regulatory standing or international relocation take longer, and we plan for that at the outset.
Yes. Where you cannot wait for a full retained search, we place experienced interim leaders within days to hold a function steady or deliver a defined programme with a clear end point.
Speak to Our Life Sciences Executive Search Team
Before your next senior appointment, one question is worth sitting with. Are you about to hire someone who knows what good looks like in this sector, or someone who has actually built it?
If that is a conversation worth having, it is exactly the one we welcome.
Talk to us about a senior appointmentLeadership Insights for Life Sciences and Healthcare
Observations from twenty years of appointing leaders into complex organisations: what separates an appointment that compounds from one that quietly comes apart, why succession plans drift towards the most visible candidate, and what a board ought to ask before it signs off the brief.
No Burning Platform, No Transformation
Some companies are so successful that they never have to be brilliant. Think about the organisations that dominate their markets so completely that urgency simply does not exist. The revenue keeps coming. The brand carries weight. The infrastructure is established. And somewhere inside that comfort, the standard of leadership quietly settles into something unremarkable.
The Leadership Health Check: Is Your Executive Team Built for 2026?
Trust in senior leaders is also under strain. Only 14% of UK workers say they have faith in senior leaders’ decisions. That erosion shows up in slower adoption of change, more challenge behind the scenes and ultimately a higher cost of making anything stick. In this environment, the most important question is not "Is our strategy right?". A better question is, "Is the leadership system at the top capable of delivering it?".
Succession Planning When the Obvious Successor Leaves Suddenly
Most succession planning assumes someone is ready to step up. But what happens when the obvious successor is the one who leaves? A look at why heir apparent plans fail, the real cost of an unplanned leadership transition, and how boards build genuine continuity.
The Character Equation: Hiring Beyond Competence
What’s 2+2 in leadership hiring? The answer isn’t always 4. Especially when you forget to account for the hidden variables: character and context. Almost 50 to 70% of new executives fail within 18 months, not for lack of skill but because hiring often overlooks character, cultural fit, and adaptability. We often think of hiring as a simple maths problem. You line up competence with experience and expect to find your next great leader. Except it rarely works out that neatly.
Culture Fit vs Culture Add - Rethinking Team Compatibility
Are you hiring for comfort or for progress? It’s an easy trap to fall into. You sit across from a candidate who reminds you of yourself ten years ago. Or maybe they mirror someone on your team who’s been successful. They “just feel right.” That’s the comfort zone of culture fit. It feels safe. It feels smooth. But here’s the risk: If everyone looks the same, thinks the same, and solves problems the same way, fresh ideas never surface.